PRKAA1 and cancer: Once activated by decreased cellular ATP/AMP ratio, AMPK stimulates catabolic pathways to maintain a sufficient energy supply and negatively regulates its downstream effector mTOR, thus modulating cancer cell proliferation, invasion and metastasis [31].